Laboratory testing for heritable thrombophilia: Impact on clinical management of thrombotic disease

被引：43

作者：

Greaves, M

Baglin, T

机构：

[1] Univ Aberdeen, Dept Med & Therapeut, Aberdeen AB25 2ZD, Scotland

[2] Addenbrookes Hosp, Dept Haematol, Cambridge CB2 2QQ, England

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2000年 / 109卷 / 04期

关键词：

thrombosis; thrombophilia; genetic screening;

D O I：

10.1046/j.1365-2141.2000.02185.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：699 / 703

页数：5

相关论文

共 26 条

[21] TAIT RC, 1993, THROMB HAEMOSTASIS, V70, P281
[22] vanBoven HH, 1996, THROMB HAEMOSTASIS, V75, P417
[23] Recurrence of venous thromboembolism in patients with familial thrombophilia
vandenBelt, AGM
Sanson, BJ
Simioni, P
Prandoni, P
Buller, HR
Girolami, A
Prins, MH
[J]. ARCHIVES OF INTERNAL MEDICINE, 1997, 157 (19) : 2227 - 2232
[24] Factor V Leiden: Should we screen oral contraceptive users and pregnant women?
Vandenbroucke, JP
vanderMeer, FJM
Helmerhorst, FM
Rosendaal, FR
[J]. BRITISH MEDICAL JOURNAL, 1996, 313 (7065) : 1127 - 1130
[25] INCREASED RISK OF VENOUS THROMBOSIS IN ORAL-CONTRACEPTIVE USERS WHO ARE CARRIERS OF FACTOR-V LEIDEN MUTATION
VANDENBROUCKE, JP
KOSTER, T
BRIET, E
REITSMA, PH
BERTINA, RM
ROSENDAAL, FR
[J]. LANCET, 1994, 344 (8935) : 1453 - 1457
[26] RESISTANCE TO ACTIVATED PROTEIN-C AS AN ADDITIONAL GENETIC RISK FACTOR IN HEREDITARY-DEFICIENCY OF PROTEIN-S
ZOLLER, B
BERNTSDOTTER, A
DE FRUTOS, PG
DAHLBACK, B
[J]. BLOOD, 1995, 85 (12) : 3518 - 3523